{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:54:21Z","timestamp":1790891661618,"version":"4.1.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1NU38CK000480"],"award-info":[{"award-number":["1NU38CK000480"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Human prion diseases are rapidly progressive and fatal neurodegenerative conditions caused by a disease-causing isoform of the native prion protein. The prion protein gene (\n                    <jats:italic>PRNP<\/jats:italic>\n                    ) encodes for the cellular prion protein, which is the biological substrate for prion disease transmission and neurotoxicity. Human prion diseases have three etiologies: sporadic, genetic, and acquired.\n                    <jats:italic>PRNP<\/jats:italic>\n                    polymorphisms and pathogenic variants play a large role in the frequency, age at onset, and clinicopathologic phenotype of prion diseases. Genetic prion diseases will be covered in detail and information necessary for clinical care, predictive genetic testing, and genetic counseling will be reviewed. Because the prion protein is necessary for transmission and neurotoxicity, many experimental treatments targeting its production are being investigated and hold potential promise as a disease modifying treatment for all forms of prion disease, including asymptomatic mutation carriers. This article will review genetic aspects of human prion disease and their influence on epidemiology, clinicopathologic phenotype, diagnostics, clinical management, and potential treatment approaches.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2022.1003056","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:55:36Z","timestamp":1664931336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Genetic aspects of human prion diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Brian S.","family":"Appleby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashirekha","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elkasaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","article-title":"Mice devoid of PrP are resistant to scrapie","volume":"73","author":"Bueler","year":"1993","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0092-8674(94)90436-7","article-title":"No propagation of prions in mice devoid of PrP","volume":"77","author":"Sailer","year":"1994","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1136\/jnnp-2012-304820","article-title":"Intensity of human prion disease surveillance predicts observed disease incidence","volume":"84","author":"Klug","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1212\/WNL.0000000000008680","article-title":"Prion disease incidence in the United States, 2003\u20132015","volume":"94","author":"Maddox","year":"2020","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","article-title":"Diagnosis of Prion diseases by RT-QuIC results in improved surveillance","volume":"95","author":"Rhoads","year":"2020","journal-title":"Neurology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/v13050789","article-title":"Clinical use of improved diagnostic testing for detection of prion disease","volume":"13","author":"Figgie","year":"2021","journal-title":"Viruses."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1001\/jamaneurol.2020.1319","article-title":"New criterion for detecting prion disease with diffusion magnetic resonance imaging: diagnostic performance and comparison with cerebrospinal fluid tests in a large autopsy cohort","volume":"132","author":"Bizzi","year":"2020","journal-title":"JAMA Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1212\/01.wnl.0000231528.65069.3f","article-title":"Iatrogenic Creutzfeldt-Jakob disease: the waning of an era","volume":"67","author":"Brown","year":"2006","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(00)02140-1","article-title":"The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease","volume":"355","author":"Zeidler","year":"2000","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain."},{"key":"B12","unstructured":"Diagnostic Criteria: CDC's Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD), 2018Diagnostic Criteria: CDC's Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD), 20182019"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/0140-6736(91)93128-V","article-title":"Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease","volume":"337","author":"Collinge","year":"1991","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/352340a0","article-title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt\u2013Jakob disease","volume":"352","author":"Palmer","year":"1991","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/353801b0","article-title":"CJD discrepancy","volume":"353","author":"Doh-ura","year":"1991","journal-title":"Nature."},{"key":"B16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10038-004-0150-7","article-title":"Polymorphisms of the prion protein gene (PRNP) in a Korean population","volume":"49","author":"Jeong","year":"2004","journal-title":"J Hum Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/jnnp-2021-328720","article-title":"Methionine homozygosity for PRNP polymorphism and susceptibility to human prion diseases","volume":"93","author":"Kosami","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3390\/cells10113132","article-title":"The first meta-analysis of the M129V Single-Nucleotide Polymorphism (SNP) of the Prion Protein Gene (PRNP) with Sporadic Creutzfeldt\u2013Jakob Disease","volume":"10","author":"Kim","year":"2021","journal-title":"Cells."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/brain\/awh249","article-title":"Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies","volume":"127","author":"Pocchiari","year":"2004","journal-title":"Brain."},{"key":"B20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jamaneurol.2015.4885","article-title":"Clinical trial simulations based on genetic stratification and the natural history of a functional outcome measure in Creutzfeldt-Jakob Disease","volume":"73","author":"Mead","year":"2016","journal-title":"JAMA Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/alz.12133","article-title":"A prognostic model for overall survival in sporadic Creutzfeldt-Jakob disease","volume":"16","author":"Llorens","year":"2020","journal-title":"Alzheimers Dement"},{"key":"B22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol."},{"key":"B23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/jnen\/nly019","article-title":"A practical primer on Prion pathology","volume":"77","author":"Appleby","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.25983","article-title":"Subtype diagnosis of sporadic Creutzfeldt\u2013Jakob disease with diffusion magnetic resonance imaging","volume":"89","author":"Bizzi","year":"2021","journal-title":"Ann Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-444-63945-5.00010-6","article-title":"\u201cVariably protease-sensitive prionopathy,\u201d Handbook of Clinical Neurology","author":"Notari","year":"2018"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1073\/pnas.1901947116","article-title":"Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development","volume":"116","author":"Vallabh","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2350-12-73","article-title":"A polymorphism in the regulatory region of PRNP is associated with increased risk of sporadic Creutzfeldt-Jakob disease","volume":"12","author":"Sanchez-Juan","year":"2011","journal-title":"BMC Med Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1474-4422(08)70265-5","article-title":"Genetic risk factors for variant Creutzfeldt\u2013Jakob disease: a genome-wide association study","volume":"8","author":"Mead","year":"2009","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/jnnp-2018-318756","article-title":"Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by the CYP4X1 gene","volume":"89","author":"Poleggi","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S1474-4422(20)30273-8","article-title":"Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study","volume":"19","author":"Jones","year":"2020","journal-title":"Lancet Neurol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-022-03603-2","article-title":"Gene expression and epigenetic markers of prion diseases","author":"Vir\u00e9","year":"2022","journal-title":"Cell Tissue Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1099\/0022-1317-75-1-23","article-title":"Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease","volume":"75","author":"Deslys","year":"1994","journal-title":"J Gen Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic Creutzfeldt-Jakob disease, final assessment","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1212\/WNL.53.6.1197","article-title":"Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France","volume":"53","author":"d'Aignaux","year":"1999","journal-title":"Neurology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1086\/317935","article-title":"Increased susceptibility to Kuru of carriers of the PRNP 129 methionine\/methionine genotype","volume":"183","author":"Lee","year":"2001","journal-title":"J Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1098\/rstb.2008.0087","article-title":"Genetic susceptibility, evolution and the kuru epidemic","volume":"363","author":"Mead","year":"2008","journal-title":"Philos Trans R Soc B Biol Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1056\/NEJMoa0809716","article-title":"A novel protective Prion protein variant that colocalizes with Kuru exposure","volume":"361","author":"Mead","year":"2009","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nature14510","article-title":"A naturally occurring variant of the human prion protein completely prevents prion disease","volume":"522","author":"Asante","year":"2015","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2350-10-146","article-title":"PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism","volume":"10","author":"Bishop","year":"2009","journal-title":"BMC Med Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJMc1610003","article-title":"Variant Creutzfeldt\u2013Jakob disease in a patient with Heterozygosity at PRNP Codon 129","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"f5675","DOI":"10.1136\/bmj.f5675","article-title":"Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey","volume":"347","author":"Gill","year":"2013","journal-title":"BMJ."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9650976","DOI":"10.1007\/s00401-020-02153-7","article-title":"Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic","volume":"139","author":"Gill","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci Transl Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/B978-0-444-63945-5.00013-1","article-title":"Genetic Creutzfeldt-Jakob disease","volume":"153","author":"Ladogana","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00401-021-02350-y","article-title":"Phenotypic diversity of genetic Creutzfeldt\u2013Jakob disease: a histo-molecular-based classification","volume":"142","author":"Baiardi","year":"2021","journal-title":"Acta Neuropathol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/B978-0-444-63945-5.00015-5","article-title":"Fatal familial insomnia and sporadic fatal insomnia","volume":"153","author":"Cracco","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/B978-0-444-63945-5.00014-3","article-title":"Dominantly inherited prion protein cerebral amyloidoses - a modern view of Gerstmann-Str\u00e4ussler-Scheinker","volume":"153","author":"Ghetti","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/v13091794","article-title":"Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion","volume":"13","author":"Brennecke","year":"2021","journal-title":"Viruses."},{"key":"B52","doi-asserted-by":"publisher","first-page":"a033134","DOI":"10.1101\/cshperspect.a033134","article-title":"Genetic PrP Prion Diseases","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","article-title":"A novel Prion disease associated with diarrhea and autonomic neuropathy","volume":"369","author":"Mead","year":"2013","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ajhg.2014.09.003","article-title":"Ascertainment bias causes false signal of anticipation in genetic prion disease","volume":"95","author":"Minikel","year":"2014","journal-title":"Am J Hum Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/19336896.2016.1254858","article-title":"Familial Creutzfeldt-Jakob disease: case report and role of genetic counseling in post mortem testing","volume":"10","author":"Clift","year":"2016","journal-title":"Prion."},{"key":"B56","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1056\/NEJMcpc2115852","article-title":"Case 5-2022: a 65-year-old woman with rapidly progressive weakness in the right arm and recurrent falls","volume":"386","author":"Stephen","year":"2022","journal-title":"N Engl J Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.psc.2015.01.008","article-title":"Genetic testing and counseling in the diagnosis and management of young-onset dementias","volume":"38","author":"Goldman","year":"2015","journal-title":"Psychiatr Clin North Am."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/ejhg.2014.42","article-title":"Predictive testing for inherited prion disease: report of 22 years experience","volume":"22","author":"Owen","year":"2014","journal-title":"Eur J Hum Genet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3389\/fgene.2019.00895","article-title":"Genetic testing in Prion disease: psychological consequences of the decisions to know or not to know","volume":"10","author":"Schwartz","year":"2019","journal-title":"Front Genet."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.06.003","article-title":"Genetic counseling for prion disease: updates and best practices","author":"Goldman","year":"2022","journal-title":"Genetics in Medicine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1212\/01.WNL.0000197984.03391.9B","article-title":"Preimplantation exclusion of embryos at risk for prion diseases","volume":"66","author":"Meiner","year":"2006","journal-title":"Neurology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coph.2018.11.006","article-title":"Therapeutic strategies for prion disease: a practical perspective","volume":"44","author":"Appleby","year":"2019","journal-title":"Curr Opin Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0304-3940(96)12596-9","article-title":"Hippocampal slices from prion protein null mice: disrupted Ca2+-activated K+ currents","volume":"209","author":"Colling","year":"1996","journal-title":"Neurosci Lett."},{"key":"B64","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/380639a0","article-title":"Altered circadian activity rhythms and sleep in mice devoid of prion protein","volume":"380","author":"Tobler","year":"1996","journal-title":"Nature."},{"key":"B65","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nn.2483","article-title":"Axonal prion protein is required for peripheral myelin maintenance","volume":"13","author":"Bremer","year":"2010","journal-title":"Nat Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0154604","DOI":"10.1371\/journal.pone.0154604","article-title":"Manipulating the prion protein gene sequence and expression levels with CRISPR\/Cas9","volume":"11","author":"Kaczmarczyk","year":"2016","journal-title":"PLoS ONE."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0269342","DOI":"10.1371\/journal.pone.0269342","article-title":"Investigating CRISPR\/Cas9 gene drive for production of disease-preventing prion gene alleles","volume":"17","author":"Castle","year":"2022","journal-title":"PLoS ONE."},{"key":"B68","doi-asserted-by":"publisher","first-page":"592571","DOI":"10.3389\/fped.2021.592571","article-title":"CRISPR gene-editing models geared toward therapy for hereditary and developmental neurological disorders","volume":"9","author":"Wong","year":"2021","journal-title":"Front Pediatr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1474-4422(19)30403-X","article-title":"Towards a treatment for genetic prion disease: trials and biomarkers","volume":"19","author":"Vallabh","year":"2020","journal-title":"Lancet Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e131175","DOI":"10.1172\/jci.insight.131175","article-title":"Antisense oligonucleotides extend survival of prion-infected mice","volume":"5","author":"Raymond","year":"2019","journal-title":"JCI Insight."},{"key":"B71","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","article-title":"Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints","volume":"48","author":"Minikel","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4161\/pri.3.3.9289","article-title":"Therapy for prion diseases","volume":"3","author":"White","year":"2009","journal-title":"Prion."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e156532","DOI":"10.1172\/jci.insight.156532","article-title":"PrP concentration in the central nervous system: regional variability, genotypic effects, and pharmacodynamic impact","volume":"7","author":"Mortberg","year":"2022","journal-title":"JCI Insight."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","article-title":"Age at onset in genetic prion disease and the design of preventive clinical trials","volume":"93","author":"Minikel","year":"2019","journal-title":"Neurology."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1038\/s41380-021-01045-w","article-title":"Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases","volume":"26","author":"Thompson","year":"2021","journal-title":"Mol Psychiatry."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1003056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:55:42Z","timestamp":1664931342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1003056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":75,"alternative-id":["10.3389\/fneur.2022.1003056"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1003056","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"article-number":"1003056"}}